4AB
ABBVIE INC. DL,01
Stock XETRA – Stock Market Prices, News & Analysis
Société pharmaceutique américaine développant des médicaments innovants dans plusieurs domaines thérapeutiques, notamment l'immunologie et l'oncologie.
ABBVIE INC. DL,01
4AB
Société pharmaceutique américaine développant des médicaments innovants dans plusieurs domaines thérapeutiques, notamment l'immunologie et l'oncologie.
Price history of ABBVIE INC. DL,01
Price history of ABBVIE INC. DL,01
Performance & Momentum
Strategic Analysis
ABBVIE INC. DL,01 • 2026
AbbVie stands out for its model focused on developing innovative treatments in immunology and oncology, relying on strong medical research capabilities. Its therapeutic diversification and solid position in high-growth segments represent a major competitive advantage.
- Diversified portfolio including flagship drugs in immunology and oncology
- Sustained innovation capability supported by significant R&D investment
- Strong positioning in the U.S. healthcare market, one of the most dynamic
- High exposure to strict regulations and the uncertainties of medical approvals
- Relative dependence on a few major products for a significant share of revenue
The positive medium- and long-term momentum reflects sustained growth dynamics and good resilience to sector cycles. This trend supports an investment approach based on confidence in AbbVie's ability to maintain its commercial development and innovation.
Similar stocks to ABBVIE INC. DL,01
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
